Llorente M - Search Results

1

The amino-terminal domain of the CCR2 chemokine receptor acts as coreceptor for HIV-1 infection.

Frade JM, Llorente M, Mellado M, Alcamí J, Gutiérrez-Ramos JC, Zaballos A, Real G, Martínez-A C. Frade JM, et al. Among authors: llorente m. J Clin Invest. 1997 Aug 1;100(3):497-502. doi: 10.1172/JCI119558. J Clin Invest. 1997. PMID: 9239395 Free PMC article.

2

Natural human antibodies retrieved by phage display libraries from healthy donors: polyreactivity and recognition of human immunodeficiency virus type 1gp120 epitopes.

Llorente M, Sánchez-Palomino S, Mañes S, Lucas P, Kremer L, De Alborán IM, Torán JL, Alcamí J, Del Real G, Martínez-A C. Llorente M, et al. Scand J Immunol. 1999 Sep;50(3):270-9. doi: 10.1046/j.1365-3083.1999.00516.x. Scand J Immunol. 1999. PMID: 10447936 Free article.

3

The matrix metalloproteinase-9 regulates the insulin-like growth factor-triggered autocrine response in DU-145 carcinoma cells.

Mañes S, Llorente M, Lacalle RA, Gómez-Moutón C, Kremer L, Mira E, Martínez-A C. Mañes S, et al. Among authors: llorente m. J Biol Chem. 1999 Mar 12;274(11):6935-45. doi: 10.1074/jbc.274.11.6935. J Biol Chem. 1999. PMID: 10066747 Free article.

4

HIV-1 envelope protein gp120 triggers a Th2 response in mice that shifts to Th1 in the presence of human growth hormone.

Mellado M, Llorente M, Rodríguez-Frade JM, Lucas P, Martínez C, del Real G. Mellado M, et al. Among authors: llorente m. Vaccine. 1998 Jul;16(11-12):1111-5. doi: 10.1016/s0264-410x(98)80106-0. Vaccine. 1998. PMID: 9682366

5

Antibody repertoire against HIV-1 gp120 triggered in nude and normal mice by GM-CSF/gp120 immunization.

del Real G, Llorente M, Lucas P, Kremer L, Torán JL, Martínez-A C. del Real G, et al. Among authors: llorente m. Mol Immunol. 1999 Aug;36(11-12):721-31. doi: 10.1016/s0161-5890(99)00090-5. Mol Immunol. 1999. PMID: 10593511

6

Molecular analysis of HIV-1 gp120 antibody response using isotype IgM and IgG phage display libraries from a long-term non-progressor HIV-1-infected individual.

Torán JL, Kremer L, Sánchez-Pulido L, de Alborán IM, del Real G, Llorente M, Valencia A, de Mon MA, Martínez-A C. Torán JL, et al. Among authors: llorente m. Eur J Immunol. 1999 Sep;29(9):2666-75. doi: 10.1002/(SICI)1521-4141(199909)29:09<2666::AID-IMMU2666>3.0.CO;2-Q. Eur J Immunol. 1999. PMID: 10508241 Free article.

7

Ablation of Dido3 compromises lineage commitment of stem cells in vitro and during early embryonic development.

Fütterer A, Raya A, Llorente M, Izpisúa-Belmonte JC, de la Pompa JL, Klatt P, Martínez-A C. Fütterer A, et al. Among authors: llorente m. Cell Death Differ. 2012 Jan;19(1):132-43. doi: 10.1038/cdd.2011.62. Epub 2011 Jun 10. Cell Death Differ. 2012. PMID: 21660050 Free PMC article.

8

Suppression of HIV-1 infection in linomide-treated SCID-hu-PBL mice.

del Real G, Llorente M, Boscá L, Hortelano S, Serrano A, Lucas P, Gómez L, Torán JL, Redondo C, Martínez C. del Real G, et al. Among authors: llorente m. AIDS. 1998 May 28;12(8):865-72. doi: 10.1097/00002030-199808000-00008. AIDS. 1998. PMID: 9631139

9

A hammerhead ribozyme targeted to the human chemokine receptor CCR5.

González MA, Serrano F, Llorente M, Abad JL, García-Ortiz MJ, Bernad A. González MA, et al. Among authors: llorente m. Biochem Biophys Res Commun. 1998 Oct 20;251(2):592-6. doi: 10.1006/bbrc.1998.9522. Biochem Biophys Res Commun. 1998. PMID: 9792818

10

Chemokine receptor-specific antibodies in cancer immunotherapy: achievements and challenges.

Vela M, Aris M, Llorente M, Garcia-Sanz JA, Kremer L. Vela M, et al. Among authors: llorente m. Front Immunol. 2015 Jan 30;6:12. doi: 10.3389/fimmu.2015.00012. eCollection 2015. Front Immunol. 2015. PMID: 25688243 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

244 results

Search Page